Efficacy Versus Hepatotoxicity of High-dose Rifampin, Pyrazinamide, and Moxifloxacin to Shorten Tuberculosis Therapy Duration: There Is Still Fight in the Old Warriors Yet!

BACKGROUND: One approach that could increase the efficacy and reduce the duration of antituberculosis therapy is pharmacokinetics/pharmacodynamics-based optimization of doses. However, this could increase toxicity. METHODS: We mimicked the concentration-time profiles achieved by human equivalent dos...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Infect Dis
Autors principals: Srivastava, Shashikant, Deshpande, Devyani, Magombedze, Gesham, Gumbo, Tawanda
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2018
Matèries:
Supplement Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6260156/
https://ncbi.nlm.nih.gov/pubmed/30496465
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciy627
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars